FDA Device recall Z-2372-2018
Zimmer¿ M/L Taper Hip Prosthesis With Kinective¿ Technology Cementless, Size 20
- FDA Device
- Class II
- terminated
- Published 2018-07-11
On 2018-07-11 the FDA classified a Class II recall of Zimmer¿ M/L Taper Hip Prosthesis With Kinective¿ Technology Cementless, Size 20 by Zimmer Biomet, citing M/L Taper Hip Prosthesis and M/L Taper Hip Prosthesis with Kinectiv Technology manufactured prior to October 2015 are being recalled due to the potential for black residue to be o….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2372-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-05-30 |
| Published | 2018-07-11 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Zimmer Biomet |
| Distribution | n/a |
Product
Zimmer¿ M/L Taper Hip Prosthesis With Kinective¿ Technology Cementless, Size 20; 00-7713-020-00
Reason
M/L Taper Hip Prosthesis and M/L Taper Hip Prosthesis with Kinectiv Technology manufactured prior to October 2015 are being recalled due to the potential for black residue to be observed within the polyethylene bag containing the implant. The black residue is a combination of the titanium plasma spray used to create the porous surface of the implant and polyethylene bag containing the implant. The recalling firm states the residue is biocompatible. Risks include delay of surgery while locating a replacement device, and surgical intervention due to wear caused by debris.
Identifiers
| code_info | 00114166 61068340 61081252 61269285 61294384 61308863 61729730 61774484 61985982 62225912 62356231 62478335 77004221 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2372-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.